SCHEMBL16483955

SCHEMBL16483955

Cc1ccccc1N(c1cccnc1)c1cccc(-c2ccc3c4c(cccc24)-c2c-3c(-c3ccccc3)c3ccccc3c2-c2ccccc2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 3/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ CYP17A1 P05093 2/20 0.34
▸ CYP1A2 P05177 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ FYN P06241 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ KCNA5 P22460 1/20 0.33
▸ MAPK14 Q16539 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ NPC1 O15118 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ NPY5R Q15761 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ AHR P35869 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ TNF P01375 1/20 0.31
▸ PIM1 P11309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16485314 0.92 CYP17A1 (0.36) CYP11B1CYP11B2CYP17A1CYP1A2KDM4E
SCHEMBL16483958 0.90 MAPK14 (0.37) CYP17A1CYP1A2KDM4ELMNAMAPK14
SCHEMBL16485078 0.90 CYP11B1 (0.40) CYP11B1CYP11B2CYP17A1CYP1A2KDM4E
SCHEMBL16483953 0.89 TNF (0.39) CYP11B1CYP11B2CYP17A1KDM4EFYN
SCHEMBL16485089 0.88 CYP11B1 (0.40) CYP11B1CYP11B2CYP17A1CYP1A2KDM4E
SCHEMBL23764294 0.88 MEN1 (0.32) KDM4EMAPK14SMN1; SMN2ALDH1A1
SCHEMBL23764150 0.87 CYP11B1 (0.36) CYP11B1CYP11B2CYP17A1CYP1A2FYN
SCHEMBL16485080 0.85 CYP11B1 (0.38) CYP11B1CYP11B2CYP17A1CYP1A2KDM4E
SCHEMBL16484070 0.85 CYP11B1 (0.38) CYP11B1CYP11B2KDM4EFYNKCNA5
SCHEMBL16484005 0.85 CYP11B1 (0.42) CYP11B1CYP11B2CYP1A2KDM4EFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2907803-B1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT TORAY INDUSTRIES (JP) 2021-08-18 — — EP disclosed
US-9935273-B2 Fluoranthene derivative, light-emitting device material containing same, and light-emitting device TORAY INDUSTRIES, INC. (JP) 2018-04-03 — — US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 — — US disclosed
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE TORAY INDUSTRIES, INC. (JP) 2015-10-01 — — US disclosed
WO-2014057874-A1 FLUORANTHENE DERIVATIVE, LUMINESCENT ELEMENT MATERIAL CONTAINING SAME, AND LUMINESCENT ELEMENT 東レ株式会社 (JP) 2014-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150280139-A1 FLUORANTHENE DERIVATIVE, LIGHT-EMITTING DEVICE MATERIAL CONTAINING SAME, AND LIGHT-EMITTING DEVICE FMNL1, AFF2, LEF1 CYP11B1 4354/4885CYP11B2 3859/4885CYP17A1 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback